logo

Endo International Plc (ENDP)



Trade ENDP now with
  Date
  Headline
3/1/2019 7:32:15 AM Endo To Present Data From Two Abstracts On Collagenase Clostridium Histolyticum
2/28/2019 6:32:26 AM Endo Q4 Loss Per Share From Cont Opns $1.18; AdjEPS From Cont Opns Of $0.75
2/27/2019 5:17:27 PM Endo Reports Termination Of Acquisition Agreements With Somerset Therapeutics And Business Of Affiliate Wintac
2/22/2019 7:31:45 AM Paladin Labs Announces Approval Of Envarsus PA In Canada
2/7/2019 8:03:43 AM Endo Agrees Not To Oppose Addl Stay Of FDA Litigation Following Restoration Of Govt Appropriations
12/31/2018 7:31:40 AM Endo Announces Anticipated Further Stay Of Compounding Litigation Due To Lapse Of Govt Appropriations
12/18/2018 12:05:24 PM Catalyst Pharmaceuticals Announces Definitive Agreement With Endo For Vigabatrin Tablets
11/8/2018 7:03:41 AM Endo Intl. Q3 Net Loss Widens To $173.2 Mln Or $0.77/shr From $96.7 Mln Or $0.43/shr Last Year
  
 
>